Skip to Main Content
Contribute Try STAT+ Today

The following is an excerpt from STAT’s deep dive report into the Democrats running for president in 2020 and their proposals for pharmaceutical industry reform. Learn more here.

Sen. Bernie Sanders is making high drug prices a signature issue on the campaign trail. The Vermont senator, who identifies as an independent, “Democratic socialist”-style progressive, reshaped Democratic politics with his insurgent bid for the party’s nomination in 2016, and now appears to be a frontrunner for the party’s nomination in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • These all sound like excellent fair reasonable ideas that the vast majority of people do and should support

Comments are closed.